4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-063020
Chief Financial Officer sold 30,625 shares at $40.00 ($1,225,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2022-12-29 | Sale | −30,625 | $40.00 | $1,225,000 | 336,704 | D |
| Open-market sales · 30,625 sh · avg $40.00 · $1,225,000 | |||||||
Loading xslF345X03/doc4.xml…